CA
PAVM icon

Cliff Asness’s PAVmed PAVM Stock Holding History

Cliff Asness’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-78
Closed -$87K – 2271
2021
Q4 		$87K Hold
78
– – ﹤0.01% 2161
2021
Q3 		$301K Hold
78
– – ﹤0.01% 2035
2021
Q2 		$226K Hold
78
– – ﹤0.01% 2118
2021
Q1 		$157K Sell
78
-107
-58% -$161K ﹤0.01% 2135
2020
Q4 		$176K Hold
185
– – ﹤0.01% 2105
2020
Q3 		$148K Buy
+185
New +$165K ﹤0.01% 2104

Other funds holding PAVM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cliff Asness's PAVM Position: Q1 2022 in Review

Cliff Asness sold out of PAVmed (PAVM) in Q1 2022, closing a stake of 78 shares — an estimated $87K sold.

Cliff Asness first reported a position in PAVM in Q3 2020 and held it in 6 quarters. The position peaked at $301K in Q3 2021. 94 funds tracked by Wall St. Rank hold PAVM as of Q1 2022.

  • Cliff Asness reported no remaining PAVmed position as of Q1 2022 after selling out during the quarter.
  • Cliff Asness sold 78 PAVmed shares in Q1 2022, an estimated $87K.
  • Cliff Asness first reported a position in PAVmed in Q3 2020 and held it in 6 quarters.
  • Cliff Asness's PAVmed position peaked at $301K in Q3 2021.
  • 94 funds tracked by Wall St. Rank held PAVmed as of Q1 2022.

Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.